Overview

• The Supreme Court blocked Purdue Pharma's bankruptcy plan, which shielded its owners from lawsuits over the opioid epidemic.
• The blocked plan would have provided over $6 billion in funding to address the opioid crisis.
• The Justice Department argued the plan allowed the owners to improperly use bankruptcy to avoid liability.
• The Supreme Court agreed to review the case, delaying the bankruptcy plan and funding.
• There are concerns this could set a precedent for corporations to shield wealthy owners through bankruptcy.